The University of Alabama at Birmingham is a public research university in Birmingham, Alabama. Developed from an academic extension center established in 1936, the institution became a four-year campus in 1966 and a fully autonomous university in the University of Alabama System in 1969.

During the past decade, University of Alabama at Birmingham conducted 1348 clinical trials. In the 10-year time frame, 1348 clinical trials started and 750 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 645 clinical trials started and 424 clinical trials were completed. i.e. 65.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Alabama at Birmingham" #1 sponsor was "University of Alabama at Birmingham" with 614 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 90 trials sponsored, "Pfizer" with 48 trials sponsored, "NICHD Neonatal Research Network" with 46 trials sponsored and "Seagen Inc." with 46 trials sponsored. Other sponsors include 1716 different institutions and companies that sponsored additional 705 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Alabama at Birmingham" #1 collaborator was "University of Alabama at Birmingham" with 107 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 94 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 93 trials as a collaborator, "National Cancer Institute (NCI)" with 81 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 46 trials as a collaborator. Other collaborators include 2114 different institutions and companies that were collaborators in the rest 740 trials.

According to Clinical.Site data, the most researched conditions in "University of Alabama at Birmingham" are "HIV Infections" (97 trials), "Cystic Fibrosis" (70 trials), "Breast Cancer" (49 trials), "Obesity" (35 trials) and "Infant, Newborn" (33 trials). Many other conditions were trialed in "University of Alabama at Birmingham" in a lesser frequency.

Most popular intervention types in "University of Alabama at Birmingham" are "Drug" (1434 trials), "Other" (375 trials), "Device" (278 trials), "Behavioral" (225 trials) and "Biological" (162 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (360 trials), "placebo" (40 trials), "laboratory biomarker analysis" (23 trials), "Rituximab" (22 trials) and "Cyclophosphamide" (21 trials). Other intervention names were less common.

The vast majority of trials in "University of Alabama at Birmingham" are 2232 trials for "All" genders, 274 trials for "Female" genders and 58 trials for "Male" genders.

Currently, there are 709 active trials in "University of Alabama at Birmingham". 33 are not yet recruiting, 423 are recruiting, 233 are Active, not recruiting, and 20 are Enrolling by invitation. In total, there were 1499 completed trials in University of Alabama at Birmingham, 8 suspended trials, and 264 terminated clinical trials to date.

Out of the total trials that were conducted in University of Alabama at Birmingham, 315 "Phase 1" clinical trials were conducted, 682 "Phase 2" clinical trials and 596 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 121 trials, and there were also 600 trials that are defined as “Not Applicable".

University of Alabama at Birmingham has several departments that took part in Clinical trials: "University of Alabama at Birmingham Cancer Center" - 650 trials, "Univ of Alabama at Birmingham - Pediatric" - 26 trials, "UAB Lung Health Center" - 25 trials, "University of Alabama at Birmingham School of Medicine - Infectious Disease" - 19 trials, "University of Alabama at Birmingham School of Dentistry" - 15 trials, "UAB, Dept. of Ped., Div. of Infectious Diseases" - 13 trials, "UAB School of Optometry" - 13 trials, "UAB Department of Anesthesiology and Perioperative Medicine" - 12 trials, "The University of Alabama at Birmingham, Orthopaedic Trauma" - 10 trials, "UAB Youth Safety Lab, University of Alabama at Birmingham" - 8 trials, "Birmingham Psychiatry Pharmaceutical" - 8 trials, "Alabama Orthopaedic Center-Research" - 5 trials, "University of Alabama at Birmingham, Department of Obstetrics and Gynecology" - 4 trials, "UAB Epilepsy Center" - 4 trials, "University of Alabama at Birmingham - Nephrology Research Clinic" - 4 trials, "University of Alabama, Pediatric Nephrology" - 4 trials, "NIAID/DMID/CASG Central Unit" - 3 trials, "Uni Of Alabama,Birmingham; Medicine - Rheumatology" - 3 trials, "UAB Division of Cardiovascular Disease" - 3 trials, "The University of Alabama at Birmingham, Department of Dermatology" - 3 trials, "University of Alabama- Department of Urology" - 3 trials, "UAB Pediatric Eye Care; Birmingham Health Care" - 3 trials, "UAB Substance Abuse" - 2 trials, "Vascular Biology and Hypertension Program, University of Alabama at Birmingham" - 2 trials, "University of Alabama Department of Nutrition Sciences" - 2 trials